Tag: Myovant Sciences

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Myovant Sciences

BioSpace Movers & Shakers, Jan. 8

Added to Collection on: 2021-01-07 20:26:15

Tags for this article:

Companies
Takeda Pharmaceutical Company
AstraZeneca
Boehringer Ingelheim
Merck & Co.
Sangamo Therapeutics
Myovant Sciences

Click the tags to see associated articles and topics

View Article Details
Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of ...

Added to Collection on: 2021-02-17 22:12:34

Tags for this article:

Chemical compounds
Drugs
Organic compounds
Menstrual cycle
GnRH antagonists
Ethers
Triketones
Pyrimidines
Relugolix
Uterine fibroid
Heavy menstrual bleeding
Menstruation
Myovant Sciences Inc.
Myovant Sciences
Pfizer Inc.

Click the tags to see associated articles and topics

View Article Details
Sumitovant Biopharma Announces Publication in the New England Journal of Medicine of Myovant ...

Added to Collection on: 2021-02-18 00:56:15

Tags for this article:

Chemical compounds
Drugs
Organic compounds
GnRH antagonists
Ethers
Triketones
Gynaecological neoplasia
Uterine fibroid
Relugolix
Heavy menstrual bleeding
Menstruation
Medroxyprogesterone acetate
Myovant Sciences Inc.
Sumitovant Biopharma Ltd.
Myovant Sciences
New York
LONDON
New York City

Click the tags to see associated articles and topics

View Article Details
Myovant Sciences and Pfizer Announce Positive Data from Phase 3 LIBERTY Randomized ...

Added to Collection on: 2021-03-24 10:30:00

Tags for this article:

Drugs
Chemical compounds
Chemistry
Clinical research
Design of experiments
GnRH antagonists
Ethers
Triketones
Relugolix
Uterine fibroid
Medroxyprogesterone acetate
Heavy menstrual bleeding
Myovant Sciences Inc.
James Rusnak
Myovant Sciences
Juan Camilo Arjona Ferreira
Pfizer Inc.
Estradiol

Click the tags to see associated articles and topics

View Article Details
Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study ...

Added to Collection on: 2021-04-12 10:52:30

Tags for this article:

Organic compounds
Drugs
Chemical compounds
Progestogens
Estranes
GnRH antagonists
Ethers
Triketones
Relugolix
Uterine fibroid
Medroxyprogesterone acetate
Endometriosis
Pfizer Inc.
Myovant Sciences Inc.
Myovant Sciences

Click the tags to see associated articles and topics

View Article Details
Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE®, the First Once-Daily ...

Added to Collection on: 2021-05-26 20:15:00

Tags for this article:

Sex hormones
Drugs
Clinical medicine
Progestogens
Estranes
Estrogens
Prolactin releasers
Hepatotoxins
Uterine fibroid
Vaginal bleeding
Heavy menstrual bleeding
Relugolix
Myovant Sciences Inc.
Myovant Sciences
Pfizer Inc.
United States
u.s. food and drug administration
Estradiol

Click the tags to see associated articles and topics

View Article Details
Evolution Wealth Advisors, LLC Buys Invesco Optimum Yield Diversified Commodity, Financial ...

Added to Collection on: 2021-07-22 21:33:45

Tags for this article:

Exchange-traded funds
Finance
Financial markets
Money
SPDR
IShares
BlackRock
Invesco PowerShares
Corporate debt bubble
Myovant Sciences
Freeport-McMoRan Inc.
Financial Select Sector SPDR
Consumer Staples Select Sector SPDR

Click the tags to see associated articles and topics

View Article Details
FDA Makes Pfizer, Myovant Wait on Approval For Myfembree | BioSpace

Added to Collection on: 2022-05-06 13:45:12

Tags for this article:

Drugs
Menstrual cycle
Organ systems
Chemical compounds
Midwifery
Endometriosis
Ethers
GnRH antagonists
Triketones
Menstruation
Dysmenorrhea
Relugolix
Myovant
Pfizer
Myovant Sciences

Click the tags to see associated articles and topics

View Article Details
Myovant Sciences and Pfizer Receive FDA Approval of MYFEMBREE, a Once ... - Femtech Insider

Added to Collection on: 2022-08-15 06:05:06

Tags for this article:

Organic compounds
Chemical compounds
Chemistry
RTT
Progestogens
Hepatotoxins
Menstrual cycle
GnRH antagonists
Endometriosis
Uterine fibroid
Heavy menstrual bleeding
Progestin
Pfizer
Myovant Sciences
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Myovant Sciences rejects $2.5bn takeover bid from Sumitomo Pharma

Added to Collection on: 2022-10-13 10:35:17

Tags for this article:

Hormones
Chemical compounds
Organic compounds
GnRH antagonists
Ethers
Triketones
RTT
Estranes
Elagolix
Endometriosis
Relugolix
Gonadotropin-releasing hormone antagonist
Myovant
Myovant Sciences
sumitomo pharma

Click the tags to see associated articles and topics

View Article Details